Story Poster
Baylor Women's Basketball

SicEm365 Podcast: Nicki Collen Talks Transfer Portal Plans, Next Year's Roster, More

May 12, 2025
5,839

Download the SicEm365 app on the Apple App Store


Ashley Hodge talks with Baylor women’s basketball head coach Nicki Collen about next year’s roster, what to expect from returning players, how the Bears handled the transfer portal and more.


Transcript of Conversation:

*The transcript included below has been edited for brevity and clarity. It is not a word-for-word transcription of Collen’s comments.*

Ashley Hodge: Let's talk a little bit about the roster.
To continue reading, you must be a SicEm365 Premium subscriber.
Trial only available to users who have never subscribed or participated in a previous trial
Discussion from...

SicEm365 Podcast: Nicki Collen Talks Transfer Portal Plans, Next Year's Roster, More

3,498 Views | 2 Replies | Last: 1 mo ago by Ashley Hodge
blueeyedbear
How long do you want to ignore this user?
Great interview .... as usual !! Too bad you have to pry answers out of Nicki LOL

Any chance you can get a few minutes with Johnnie Harris ??
Would love to hear her thoughts on her decision to join the BU women's basketball staff and her insight with Deng and Scott
Ashley Hodge
How long do you want to ignore this user?
Staff
if you are a WBB fan and lurking on the free board... We will have quite a few premium only interviews covering WBB.

Coach Collen was gracious to give us almost an hour of her time and go up and down the roster player by player.

I also did an interview with transfers Kiera Pemberton and Talia Scott. Hope to hit other players and coaches this summer.

SicEm365 Premium Membership Benefits

$1 trial if you want to give premium a try. We are back to our roots of putting most of our content behind the paywall. If you are a Baylor sports fan, I think you will feel like the cost of a subscription is worth it.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.